Free shipping on all orders over $ 500

LDN-212854

Cat. No. M2806

All AbMole products are for research use only, cannot be used for human consumption.

LDN-212854 Structure
Synonym:

BMP Inhibitor III

Size Price Availability Quantity
Free Sample (0.1-0.5 mg)  USD 0 In stock
10mM*1mL in DMSO USD 110 In stock
1mg USD 42 In stock
2mg USD 60 In stock
5mg USD 95 In stock
10mg USD 180 In stock
25mg USD 340 In stock
50mg USD 510 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LDN-212854 is a potent and selective BMP receptor inhibitor with IC50 of 1.3 nM for ALK2, about 2-, 66-, 1641-, and 7135-fold selectivity over ALK1, ALK3, ALK4, and ALK5, respectively.

Customer Product Validations & Biological Datas
Source Oncotarget (2017). Figure 2. LDN-212854
Method i.p.
Cell Lines C57BL/6J mice
Concentrations 6 mg/kg
Incubation Time -
Results "CNV size in eyes from metformin treated group was significantly smaller than the PBS treated controls and vascular density in the CNV lesion was also less (p<0.05). In another set of experiment, animals were treated by intraperitoneal injection of PBS or LDN-212854 (6 mg/kg, twice daily), an ALK1/2 specific inhibitor. LDN-212854 also significantly inhibited laser-induced CNV and vascular density"
Chemical Information
Molecular Weight 406.48
Formula C25H22N6
CAS Number 1432597-26-6
Solubility (25°C) DMSO 35 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Han Chen, et al. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma

[2] Lanqing Fu, et al. KR‑12‑a6 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells via BMP/SMAD signaling

[3] Maiko Omi, et al. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway

[4] Eleanor Williams, et al. Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2

[5] Agustin H Mohedas, et al. Development of an ALK2-biased BMP type I receptor kinase inhibitor

Related ALK Products
AP26113 (Brigatinib)

AP26113 (Brigatinib) is a highly potent ALK inhibitor with IC50 of 0.6 nM.

X-376

X-376 is a potent and highly specific ALK small molecule tyrosine kinase inhibitor with IC50 of 0.61 nM.

SB431542

SB-431542 is a potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor activin receptor-like kinase ALK5 (IC50 = 94 nM).

RepSox

RepSox (ALK5 Inhibitor II) is a potent and ATP-competitive inhibitor of the TGF-β type I receptor ALK5 (IC50 values are 0.004 and 0.023 μM for ALK5 autophosphorylation and ALK5 binding respectively).

LDN-193189

LDN-193189 is a highly potent small molecule inhibitor of bone morphogenetic protein (BMP) type I receptors ALK2 and ALK3.

  Catalog
Abmole Inhibitor Catalog




Keywords: LDN-212854, BMP Inhibitor III supplier, ALK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.